Table 1.

Likelihood of successful opioid use outcomes at Phase 2, weeks 9-12^a

Table 1a. All participants (N=360)
	OR	95% CI	p value
Main effects
Heroin	2.0	1.3-3.3	.004
Chronic pain	1.3	0.8-2.0	.240
Drug severity	2.9	0.2-58.2	.484
Interaction with Phase 2 treatment
Heroin	1.6	0.6-4.2	.342
Chronic pain	0.6	0.2-1.4	.218
Drug severity	0.2	0.0-76.8	.585

Table 1b. Participants with adequate adherence to treatment (n=266)
	OR	95% CI	p value
Main effect of Phase 2 treatment	0.7	0.4-1.1	.107
Interaction with Phase 2 treatment
Heroin	3.7	1.1-11.8	.03
Chronic pain	0.5	0.2-1.5	.213
Drug severity	1.5	0.001-4023.5	.915

^aAll models were adjusted for Phase 1 treatment condition.